| NCT Number | NCT06891196 |
| Lead Sponsor | Mayo Clinic |
| Conditions | Hip Dysplasia, Legg-Calvâe-Perthes Disease, Avascular Necrosis of Hip |
| Enrollment | 500 participants |
| Start Date | 2025-01-15 |
| Primary Completion | 2027-01-15 (estimated) |
| Study Completion | 2027-01-15 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-03 |